Rapidly progressive graft vasculopathy in a heart transplant recipient with confirmed SARS-CoV-2 infection

Transpl Infect Dis. 2024 Feb;26(1):e14225. doi: 10.1111/tid.14225. Epub 2023 Dec 28.

Authors

Micaela MacKay¹, Madison Clewis¹, Wissam Khalife²

Affiliations

¹ The University of Texas Medical Branch John Sealy School of Medicine, Galveston, Texas, USA.
² Division of Cardiovascular Medicine, The University of Texas Medical Branch, Galveston, Texas, USA.

PMID: 38152037
DOI: 10.1111/tid.14225

No abstract available

Publication types

Letter

MeSH terms

COVID-19*
Graft Rejection
Heart Transplantation* / adverse effects
Humans
SARS-CoV-2
Transplant Recipients
Vascular Diseases*